Literature DB >> 16000637

Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections.

Lachlan Thompson1, Perrine Barraud, Elin Andersson, Deniz Kirik, Anders Björklund.   

Abstract

Transplants of fetal ventral mesencephalic tissue are known to contain a mixture of two major dopamine (DA) neuron types: the A9 neurons of the substantia nigra pars compacta (SNpc) and the A10 neurons of the ventral tegmental area (VTA). Previous studies have suggested that these two DA neuron types may differ in their growth characteristics, but, because of technical limitations, it has so far been difficult to identify the two subtypes in fetal ventral mesencephalon (VM) grafts and trace their axonal projections. Here, we have made use of a transgenic mouse expressing green fluorescent protein (GFP) under the tyrosine hydroxylase promoter. The expression of the GFP reporter allowed for visualization of the grafted DA neurons and their axonal projections within the host brain. We show that the SNpc and VTA neuron subtypes in VM grafts can be identified on the basis of their morphology and location within the graft, and their expression of a G-protein-gated inwardly rectifying K+ channel subunit (Girk2) and calbindin, respectively, and also that the axonal projections of the two DA neuron types are markedly different. By retrograde axonal tracing, we show that dopaminergic innervation of the striatum is derived almost exclusively from the Girk2-positive SNpc cells, whereas the calbindin-positive VTA neurons project to the frontal cortex and probably also other forebrain areas. The results suggest the presence of axon guidance and target recognition mechanisms in the DA-denervated forebrain that can guide the growing axons to their appropriate targets and indicate that cell preparations used for cell replacement in Parkinson's disease will be therapeutically useful only if they contain cells capable of generating the correct nigral DA neuron phenotype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16000637      PMCID: PMC6725273          DOI: 10.1523/JNEUROSCI.1676-05.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  43 in total

1.  The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.

Authors:  P Damier; E C Hirsch; Y Agid; A M Graybiel
Journal:  Brain       Date:  1999-08       Impact factor: 13.501

2.  Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells.

Authors:  S H Lee; N Lumelsky; L Studer; J M Auerbach; R D McKay
Journal:  Nat Biotechnol       Date:  2000-06       Impact factor: 54.908

Review 3.  Transplantation in the rat model of Parkinson's disease: ectopic versus homotopic graft placement.

Authors:  C Winkler; D Kirik; A Björklund; S B Dunnett
Journal:  Prog Brain Res       Date:  2000       Impact factor: 2.453

4.  Specification of distinct dopaminergic neural pathways: roles of the Eph family receptor EphB1 and ligand ephrin-B2.

Authors:  Y Yue; D A Widmer; A K Halladay; D P Cerretti; G C Wagner; J L Dreyer; R Zhou
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

5.  Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model.

Authors:  Lars M Bjorklund; Rosario Sánchez-Pernaute; Sangmi Chung; Therese Andersson; Iris Yin Ching Chen; Kevin St P McNaught; Anna-Liisa Brownell; Bruce G Jenkins; Claes Wahlestedt; Kwang-Soo Kim; Ole Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

6.  Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons.

Authors:  K Sawamoto; N Nakao; K Kobayashi; N Matsushita; H Takahashi; K Kakishita; A Yamamoto; T Yoshizaki; T Terashima; F Murakami; T Itakura; H Okano
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

7.  Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration.

Authors:  D Kirik; C Winkler; A Björklund
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

8.  Specific Reinnervation of Lesioned Mouse Striatum by Grafted Mesencephalic Dopaminergic Neurons.

Authors:  Alessandro Zuddas; Giovanni U. Corsini; Jeffery L. Barker; Irwin J. Kopin; Umberto Di Porzio
Journal:  Eur J Neurosci       Date:  1991-10       Impact factor: 3.386

9.  Efferent Projections to the Host Brain from Intrastriatal Striatal Mouse-to-rat Grafts: Time Course and Tissue-type Specificity as Revealed by a Mouse Specific Neuronal Marker.

Authors:  K. Wictorin; C. F. Lagenaur; R. D. Lund; A. Björklund
Journal:  Eur J Neurosci       Date:  1991-10       Impact factor: 3.386

10.  Differential expression of GDNF, BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion.

Authors:  D M Yurek; A Fletcher-Turner
Journal:  Brain Res       Date:  2001-02-09       Impact factor: 3.252

View more
  88 in total

1.  Tracking differentiating neural progenitors in pluripotent cultures using microRNA-regulated lentiviral vectors.

Authors:  Rohit Sachdeva; Marie E Jönsson; Jenny Nelander; Agnete Kirkeby; Carolina Guibentif; Bernhard Gentner; Luigi Naldini; Anders Björklund; Malin Parmar; Johan Jakobsson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells.

Authors:  Stina Friling; Elisabet Andersson; Lachlan H Thompson; Marie E Jönsson; Josephine B Hebsgaard; Evanthia Nanou; Zhanna Alekseenko; Ulrika Marklund; Susanna Kjellander; Nikolaos Volakakis; Outi Hovatta; Abdeljabbar El Manira; Anders Björklund; Thomas Perlmann; Johan Ericson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-21       Impact factor: 11.205

3.  Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonism.

Authors:  Daniella Rylander; Vincenza Bagetta; Valentina Pendolino; Elisa Zianni; Shane Grealish; Fabrizio Gardoni; Monica Di Luca; Paolo Calabresi; M Angela Cenci; Barbara Picconi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-29       Impact factor: 11.205

4.  Nucleotides affect neurogenesis and dopaminergic differentiation of mouse fetal midbrain-derived neural precursor cells.

Authors:  Jasmin Delic; Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2011-01-06       Impact factor: 3.765

5.  Molecular organization and timing of Wnt1 expression define cohorts of midbrain dopamine neuron progenitors in vivo.

Authors:  Ashly Brown; Jason T Machan; Lindsay Hayes; Mark Zervas
Journal:  J Comp Neurol       Date:  2011-10-15       Impact factor: 3.215

6.  Identification of Neurexophilin 3 as a Novel Supportive Factor for Survival of Induced Pluripotent Stem Cell-Derived Dopaminergic Progenitors.

Authors:  Kaneyasu Nishimura; Shigeo Murayama; Jun Takahashi
Journal:  Stem Cells Transl Med       Date:  2015-06-03       Impact factor: 6.940

7.  Visualization and genetic modification of resident brain microglia using lentiviral vectors regulated by microRNA-9.

Authors:  Malin Åkerblom; Rohit Sachdeva; Luis Quintino; Erika Elgstrand Wettergren; Katie Z Chapman; Giuseppe Manfre; Olle Lindvall; Cecilia Lundberg; Johan Jakobsson
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

8.  Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats.

Authors:  Dali Yang; Zhi-Jian Zhang; Michael Oldenburg; Melvin Ayala; Su-Chun Zhang
Journal:  Stem Cells       Date:  2007-10-18       Impact factor: 6.277

9.  The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease.

Authors:  Shane Grealish; Marie E Jönsson; Meng Li; Deniz Kirik; Anders Björklund; Lachlan H Thompson
Journal:  Brain       Date:  2010-01-31       Impact factor: 13.501

10.  Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease.

Authors:  A Vinuela; P J Hallett; C Reske-Nielsen; M Patterson; T D Sotnikova; M G Caron; R R Gainetdinov; O Isacson
Journal:  Brain       Date:  2008-11-06       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.